Comparative mutational analysis of pulmonary scar epithelium, bronchioloalveolar carcinomas, and invasive well-differentiated pulmonary adenocarcinomas: A molecular approach to diagnostically challenging cases

American Journal of Surgical Pathology

Volumn 29, Issue 10, 2005, Pages 1267-1273

  Sheikh, Hina A ^a,c   Sasatomi, Eizaburo ^a   Finkelstein, Sydney ^b   Yousem, Samuel A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b RedPath Integrated Pathology   (United States)

^c NONE   (United States)

Author keywords

Bronchioloalveolar carcinoma; Fractional allelic loss; Loss of heterozygosity; Pulmonary scar

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DNA; MOLECULAR MARKER; PROTEIN P53; PROTEIN P63;

ADULT; AGED; ALLELE; ARTICLE; CANCER INVASION; CANCER STAGING; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENE LOSS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MALE; MUTATIONAL ANALYSIS; OPEN LUNG BIOPSY; POLYMERASE CHAIN REACTION; PULMONARY SCAR EPITHELIUM; SCAR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CICATRIX; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG DISEASES; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION; RESPIRATORY MUCOSA;

EID: 25444464880     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000170999.79976.3a     Document Type: Article

References (26)

1. Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours. Eur Respir J. 2001;18:1059-1068.
2. Deleted in proof.
3. Colby TV. Malignancies in the lung and pleura mimicking benign processes. Semin Diagn Pathol. 1995;12:30-44.
4. Guinee D Jr, Fleming M, Hayashi T, et al. Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am J Pathol. 1996;149:531-538.
5. Huang MS, Colby TV, Themeau TM, et al. DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry. Cytometry. 1996;26:253-259.
6. Ishikawa Y, Furuta R, Miyoshi T, et al. Loss of heterozygosity and the smoking index increase with decrease in differentiation of lung adenocarcinomas: etiologic implications. Cancer Lett. 2002;187:47-51.
7. Kawasaki M, Noguchi M, Morikawa A, et al. Nuclear p53 accumulation by small-sized adenocarcinomas of the lung. Pathol Int. 1996;46:486-490.
8. Kitaguchi S, Takeshima Y, Nishisaka T, et al. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung. Hiroshima J Med Sci. 1998;47:17-25.
9. Kitamura H, Kameda Y, Nakamura N, et al. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma: analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol. 1996;20:553-562.
10. Kodama T, Biyajima S, Watanabe S, et al. Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. Am J Clin Pathol. 1986;85:146-151.
11. Kunitake R, Kuwano K, Miyazaki H, et al. Expression of p53, p21 (Waf1/Cip1/Sdi1) and Fas antigen in collagen vascular and granulomatous lung diseases. Eur Respir J. 1998;12:920-925.
12. Meyer EC, Liebow AA. Relationship of interstitial pneumonia honey-combing and atypical epithelial proliferation to cancer of the lung. Cancer. 1965;18:322-351.
13. Nakayama H, Noguchi M, Tsuchiya R, et al. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. Mod Pathol. 1990;3:314-320.
14. Niho S, Yokose T, Suzuki K, et al. Monoclonality of atypical adenomatous hyperplasia of the lung. Am J Pathol. 1999;154:249-254.
15. Powell CA, Bueno R, Borczuk AC, et al. Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers. Lung Cancer. 2003;39:23-29.
16. Raja S, Finkelstein SD, Baksh FK, et al. Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus. Ann Thorac Surg. 2001;72:1130-1135.
17. Sasatomi E, Johnson LR, Aldeeb DN, et al. Genetic profile of cumulative mutational damage associated with early pulmonary adenocarcinoma: bronchioloalveolar carcinoma vs. stage I invasive adenocarcinoma. Am J Surg Pathol. 2004;28:1280-1288.
18. Sozzi G, Miozzo M, Donghi R, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res. 1992;52:6079-6082.
19. Travis WDBE, Muller-Hermelink HK, Harris CC, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press, 2004.
20. Tsuchiya E, Nakamura Y, Weng SY, et al. Allelotype of non-small cell lung carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res. 1992;52:2478-2481.
21. Westra WH, Baas IO, Hruban RH, et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res. 1996;56:2224-2228.
22. Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 1999;18:643-650.
23. Wistuba II, Behrens C, Virmani AK, et al. Allelic losses at chromosome 8p21 -23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res. 1999;59:1973-1979.
24. Wistuba II, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000;60:1949-1960.
25. Yoshikawal T, Aoyagi Y, Kodama K, et al. Topographical distribution of allelic loss in individual lung adenocarcinomas with lymph node metastases. Mod Pathol. 2004;17:204-213.
26. Yoshioka H, Takeuchi T, Matsuno Y, et al. Analysis of loss of heterozygosity in small adenocarcinomas of the lung. Jpn J Clin Oncol. 1998;28:240-244.